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Sleep deprivation and antidepressant treatment
The main limitation is the transient nature of the effect,
since the majority—but not all—of the improved patients
experience a relapse after the next night of sleep.
2
Despite the rapid effects and low risk of relevant side
effects (Table I),
2-9 the method has remained an “orphan
drug” or “orphan method.”This may be explained not
only by the effort and motivation needed by the patient
and by the frequent relapses after the next night of sleep,
but also by the lack of funding for nonpharmacological
and nonneurochemical research. Nevertheless, some
progress has been made within the last few years.A vari-
ety of studies have focused on the problem of how to
avoid relapses occurring after the next night of sleep and
additionally treated the patients with light therapy,
lithium, or other drugs. Lower relapse rates after SD
were found when SD was combined with one of these
therapeutic options (Table II).
10-20
A further strategy has been to advance the sleep period
to an “unphysiological”time.Several uncontrolled stud-
ies in small numbers of patients have indicated that this
phase advance procedure per se acts as an antidepres-
sant.More recent studies have combined SD with a sub-
sequent phase advance of the sleep period, over the
course of either six or three nights and consistently found
that a phase advance of the sleep period stabilizes the
antidepressant effect of SD in about 60% of those
patients who responded positively to SD.
17-20 Only one
study also included a control group which participated in
a phase-delay protocol after SD instead of a phase-
advance protocol.
18 Significantly more patients relapsed
in the phase-delay protocol compared with the phase
advance protocol (Figure 1).This indicates that the high
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The mood-improving effect of sleep deprivation (SD) in depression is even today still not fully
understood. Despite the fact that mood and cognitive functions are lowered by prolonged sleep
loss and despite convincing data that insomnia is a strong risk factor for subsequent depression,
1
acute SD for one night or even partial SD in the second half of the night improves mood in
about 60% of depressed patients the day after.
2,3 In this respect, among all types of antidepressant
treatments, SD elicits the fastest results, faster even than electroconvulsive therapy. Many authors
correlate the likelihood of responding to SD with clinical variables.A summary of predictors is
listed in Table I.
Table I. Clinical predictors of an antidepressant response to sleep depri-
vation (SD) in depressed subjects and side effects. *Not based on
systematic documentation.
Predictive
• High level of arousal
4
• High variability of mood swings
5
• Diurnal and day-to-day mood variations
6
• “Endogenous” and melancholic subtype
2,3
• Bipolar subtype
7
Not predictive
2,3
• Age
• Sex
• Severity of depression
• Duration of depressive episode
• Duration of illness
• Earlier treatments
• Expectation of patients 
Side effects of SD in depression* 
• Tiredness, fatigue 
• Switch to hypomania or mania in bipolar patients
8
• Exacerbation of psychotic symptoms in psychotically 
depressed patients
9
• Lowering of seizure threshold
Table II. Therapeutic strategies to avoid relapses after successful sleep
deprivation in depression (selected papers).
• Antidepressants (clomipramine)
10
• Lithium
11-13
• Pindolol
14
• Light therapy
15,16
• Sleep phase advance over 3 to 6 nights
17-20response rate after SD and phase advance cannot be
explained by a placebo phenomenon alone and supports
the hypothesis that,in depressed subjects,sleeping at cer-
tain phases of the circadian rhythm,ie,especially late in
the night and in the morning,has depressogenic effects.
Unfortunately, one major issue has been almost com-
pletely neglected by researchers:does SD produce any
lasting effects after 4 to 6 weeks, which is the typical
period for measuring the effects of antidepressants?
There is only one controlled study using such a design.
21
Twenty-four patients received amitriptyline without addi-
tional SD,whereas 27 patients received amitriptyline plus
a series of 6 partial SDs.Observer ratings,but not patient
ratings,demonstrated superiority of the combined treat-
ment after 4 weeks.By the standards of evidence-based
medicine,there is little evidence to date that SD therapy
has lasting effects over the course of several weeks.
Neurobiology of SD in depression
There is no generally accepted hypothesis concerning
the mechanism of action of SD, nor an explanation for
the observation that subsequent sleep after SD leads to
relapses. A variety of neurobiological effects point
toward potential mechanisms of action of the procedure
(Table III).
22-32
Based on the observations that hyperarousal and a high
level of activation predict a favorable SD response,
4 the
antidepressant effect was explained using the two-process
model of sleep regulation (Figure 2).
33 In this model,
depressed patients have a deficiency of process S (ie,sleep
need) with process C (circadian rhythm) remaining unaf-
fected.Depression is characterized by a deficient build-up
of process S (Figure 2).SD transiently leads to an increase
in process S to normal, whereas relapse occurs after
“recovery sleep”due to a return to low levels of S.
Several brain imaging studies have tried to correlate the
SD response with metabolic states of certain brain areas.
Two early studies using single photon emission computed
tomography (SPECT)
22 and positron emission tomogra-
phy (PET),
23 respectively,found higher metabolic rates
in limbic areas in responders compared with nonrespon-
ders.A more recent study
24 confirmed these earlier find-
ings: responders to SD had higher relative metabolic
rates in the ventral anterior cingulate and in the medial
prefrontal cortex (Figure 3),as well as in the posterior
subcallosal gyrus at baseline than depressed patients who
did not respond to SD and normal volunteers.After SD,
significant decreases in metabolic rates occurred in the
medial prefrontal cortex and frontal pole in the patients
who responded positively to SD.The brain imaging stud-
ies convincingly demonstrated that acute antidepressant
SD is able to change metabolic states of brain areas that
are involved in mood regulation.
Many studies have assessed endocrine parameters before
and after SD.The results have been inconsistent,which
may be partially explained by methodological shortcom-
ings.Several authors favor the hypothesis that the hypo-
thalamo-pituitary-thyroid (HPT) axis plays a key role in
mediating the antidepressant effects of SD.
31,32
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Figure 1. Antidepressant effects of total sleep deprivation (TSD) in one
night with a consecutive phase advance of the sleep period
(blue circles) in comparison with a phase delay of the sleep
period (gray circles). In the phase-advance group, the antide-
pressant effect of SD (between day 0 and day 1) was stabilized
until day 8, whereas in the phase-delay group mood worsened
again (mood was measured by a short version of the Hamilton
Depression Rating Scale [HDRS], containing 6 items). This scale
is suitable for frequent ratings, whereas the 21-item HDRS
would not have been adequate within the study design.
18
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Table III. Neurobiological effects of sleep deprivation. In humans some
of the studies were performed in depressed patients, while
other studies were in healthy subjects or in depressed patients
and healthy subjects. 
• Decrease in limbic hypermetabolism
22-24
• Increase in dopamine turnover
25
• Increase in peripheral cytokines
26,27
• Increase in cortisol
28-30
• Increase in growth hormone secretion (recovery sleep)
30
• Increase in thyroid hormones
31,32368
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Another issue is the impact of SD on the hypothalamo-
pituitary-adrenal (HPA) axis.Increased activity of this
axis is one of the most consistent abnormalities in depres-
sion and normalization of this hyperactivity is a correlate
of clinical remission and has been suggested as the mech-
anism of action of antidepressant treatment.
34 In healthy
humans, acute SD increases cortisol secretion.
28,29 In a
study that we conducted ourselves,we found a significant
stimulatory effect of acute SD on nighttime cortisol in a
group of unmedicated depressed subjects,which was not
related to treatment response.
30 However,during the first
Figure 2. Two-process model of sleep deprivation (SD) and depression .
This model can explain the antidepressant effect of SD by
assuming that an insufficient build-up of process S (S stands
for sleep need), SD transiently increases the level of process S,
thus, leading to the antidepressant effect. Recovery sleep
decreases process S to baseline levels leading to relapse into
the depressed state. This model fits well with clinical observa-
tions that depressed patients have hyperarousal, which has
been shown to be a positive predictor of the SD response.
4
Reproduced from reference 33: Borbély AA, Wirz-Justice A. Sleep, sleep
deprivation and depression. Hum Neurobiol. 1982;1:205-210. Copyright
© 1982, Springer Verlag.
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In summary, the SD response in depressive patients remains a highly interesting issue for 
depression research, since, contrary to all antidepressant drugs, it may significantly ameliorate
mood within one day. Understanding this effect and optimizing the duration of the effect, ie,
preventing relapse after the response, might improve our ability to treat depression.
Figure 3. Positron emission tomography (PET) scan of depressed patients
who respond to total sleep deprivation (SD) in one night.
24 At
baseline, responders to SD had higher metabolic rates in the
ventral anterior cingulate and in the medial prefrontal cortex.
The study confirmed earlier findings demonstrating an asso-
ciation between high metabolic rates in limbic areas and the
likelihood to respond to SD.
22,23
Adapted from reference 24: Wu J, Buchsbaum MS, Gillin JC, et al.
Prediction of antidepressant effects of sleep deprivation by metabolic
rates in the ventral anterior cingulate and medial prefrontal cortex. Am
J Psychiatry. 1999;156:1149-1158. Copyright © 1999, American
Psychiatry Association.
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half of the day after the night,SD responders in contrast
to nonresponders had higher cortisol concentrations
compared with the day before SD.This finding does not
necessarily contradict the above relationship between
depression and HPA axis hyperactivity for two reasons.
First,the acute effects of antidepressant treatments on
the HPA axis may differ from the chronic effects.It has
been shown that electroconvulsive treatment and anti-
depressants also initially stimulate the HPA axis.Second,
two studies demonstrated acute antidepressant effects of
cortisol infusion compared with placebo.
35,36
Another theory that possibly provides a link to the HPA
effects of SD focuses on the psychostimulant effects.
Earlier studies reported an increase in dopamine,norepi-
nephrine,and serotonin after SD,ie,similar neurobiolog-
ical effects as after the intake of psychostimulants like
amphetamines (see reference 25 for an overview).Support
for a psycho-stimulant theory also comes from brain imag-
ing data,demonstrating effects of psychostimulants such
as amphetamines on metabolic rates similar to those
observed in SD.
37 Since there is a functional coupling of
psychostimulant effects and the HPA axis,
38 a cortisol
increase following SD might therefore mediate psychos-
timulant-like actions of increased aminergic neurotrans-
mitter release.
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